Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Extensively Drug-Resistant”

39 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 39 results

Large-scale testing (Phase 3)Study completedNCT06739382
What this trial is testing

Management of Ventilation Acquired Pneumonia Caused by Pseudomonas and Acinetobacter Organisms in a Pediatric Center

Who this might be right for
Ventilation Acquired Pneumonia
Beni-Suef University 64
Post-approval studies (Phase 4)Study completedNCT07445282
What this trial is testing

This Randomized Controlled Trial Evaluates the Comparative Efficacy of Intravenous Meropenem Alone Versus Intravenous Meropenem Combined With Oral Azithromycin in Children Aged 6 Months to Under 5 Years Diagnosed With Blood Culture-confirmed Extensively Drug-resistant Uncomplicated Typhoid Fever

Who this might be right for
Extensively Drug-Resistant Typhoid FeverTyphoid FeverSalmonella Typhi Infection
Sheikh Zayed Medical College 90
Testing effectiveness (Phase 2)Study completedNCT04179500
What this trial is testing

A Trial to Evaluate the Male Reproductive Safety of Pretomanid in Adult Male Participants With Drug Resistant Pulmonary Tuberculosis

Who this might be right for
Tuberculosis, PulmonaryTuberculosis, Multidrug-ResistantTuberculosis, MDR+2 more
Global Alliance for TB Drug Development 26
Large-scale testing (Phase 3)Study completedNCT03086486
What this trial is testing

Various Doses and Durations of Linezolid Plus Bedaquiline & Pretomanid in Participants With Drug Resistant Tuberculosis

Who this might be right for
Tuberculosis, PulmonaryTuberculosis, Multidrug-ResistantTuberculosis, MDR+4 more
Global Alliance for TB Drug Development 181
Large-scale testing (Phase 3)WithdrawnNCT02134106
What this trial is testing

Randomized-controlled Trial (RCT) on Combination Antibiotic for Infections Caused by Gram-negative Bacteria

Who this might be right for
BacteremiaHealthcare-associated PneumoniaVentilator-associated Pneumonia
Tan Tock Seng Hospital
Testing effectiveness (Phase 2)Study completedNCT00727844
What this trial is testing

Linezolid to Treat Extensively-Drug Resistant Tuberculosis

Who this might be right for
Pulmonary TuberculosisMultidrug Resistant TuberculosisExtensively Drug Resistant Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 41
Large-scale testing (Phase 3)Study completedNCT02589782
What this trial is testing

Pragmatic Clinical Trial for a More Effective Concise and Less Toxic MDR-TB Treatment Regimen(s)

Who this might be right for
Tuberculosis, Multidrug-ResistantExtensively Drug-Resistant TuberculosisTuberculosis, Pulmonary
Medecins Sans Frontieres, Netherlands 552
Not applicableStudy completedNCT03622918
What this trial is testing

Colistin-rifampin Combination and Colistin Monotherapy in Extensively Drug-resistant Acinetobacter Baumannii

Who this might be right for
ColistinRifampinAcinetobacter Infections
Gangnam Severance Hospital 9
Not applicableLooking for participantsNCT01212003
What this trial is testing

Training Protocol on the Natural History of Tuberculosis

Who this might be right for
Mycobacterium InfectionsTuberculosis, Multidrug-ResistantLatent Tuberculosis+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 150
Post-approval studies (Phase 4)Looking for participantsNCT07314281
What this trial is testing

Meropenem vs Azithromycin Efficacy in Case XDR Enteric Fever

Who this might be right for
Enteric Fever
Indus Hospital and Health Network 40
Not applicableApproved For MarketingNCT01464762
What this trial is testing

Early Access of TMC207 in Patients With Extensively Drug Resistant or Pre-XDR Pulmonary Tuberculosis

Who this might be right for
Tuberculosis
Janssen Infectious Diseases BVBA
Not applicableStudy completedNCT03767374
What this trial is testing

Risk-factors for Multidrug-resistant Bacteria Colonization Among Patients at High Risk of STIs

Who this might be right for
Bacterial InfectionsHIV Infections
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba 2,186
Testing effectiveness (Phase 2)UnknownNCT02060149
What this trial is testing

The Effect of Nebulization of Alkaline Solution on Treating XDRAB Pneumonia With C/S Plus Minocycline

Who this might be right for
Pneumonia
Xijing Hospital 90
Not applicableUnknownNCT03507816
What this trial is testing

A Multidrug-resistant (MDR) and Extensively Drug- Resistant (XDR) Tuberculosis Study in Alsace

Who this might be right for
Tuberculosis
University Hospital, Strasbourg, France 22
Large-scale testing (Phase 3)Study completedNCT04062201
What this trial is testing

Building Evidence for Advancing New Treatment for Rifampicin Resistant Tuberculosis (RR-TB) Comparing a Short Course of Treatment (Containing Bedaquiline, Delamanid and Linezolid) With the Current South African Standard of Care

Who this might be right for
TuberculosisPre-XDR-TBExtensively Drug-Resistant Tuberculosis+2 more
Wits Health Consortium (Pty) Ltd 402
Large-scale testing (Phase 3)Study completedNCT02454205
What this trial is testing

An Open-label RCT to Evaluate a New Treatment Regimen for Patients With Multi-drug Resistant Tuberculosis

Who this might be right for
TuberculosisMultidrug Resistant TuberculosisExtensively-drug Resistant Tuberculosis
University of Cape Town 154
Large-scale testing (Phase 3)Study completedNCT03896685
What this trial is testing

Evaluating Newly Approved Drugs in Combination Regimens for Multidrug-Resistant TB With Fluoroquinolone Resistance (endTB-Q)

Who this might be right for
Tuberculosis, Multidrug-ResistantTuberculosisPulmonary Tuberculoses+3 more
Médecins Sans Frontières, France 323
Large-scale testing (Phase 3)Study completedNCT04207112
What this trial is testing

Economic Evaluation of New MDR TB Regimens

Who this might be right for
Multi-drug Resistant TuberculosisExtensively Drug-Resistant TuberculosisPulmonary Tuberculoses
Medecins Sans Frontieres, Netherlands 73
Post-approval studies (Phase 4)Study completedNCT01521364
What this trial is testing

Drug Interaction Study Between Linezolid and Clarithromycin in Tuberculosis Patients

Who this might be right for
Multidrug-resistant TuberculosisExtensively Drug-resistant Tuberculosis
University Medical Center Groningen 7
Large-scale testing (Phase 3)WithdrawnNCT01600963
What this trial is testing

Evaluate the Efficacy and Safety of TMC207 in Patients With Pulmonary Infection With Multi-drug Resistant Mycobacterium Tuberculosis

Who this might be right for
Multi-drug Resistant Tuberculosis
Janssen Infectious Diseases BVBA
Next Page